Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Job title: Deputy Director
Dr Lawrence N Shulman is Deputy Director for Clinical Services at the Abramson Cancer Center at the University of Pennsylvania. He is also Director of the Center for Global Cancer Medicine. Currently Dr Shulman is Chair of the Commission on Cancer and serves on the National Cancer Policy Forum of the National Academy. Formerly, he was Chair of the American Society of Clinical Oncology Quality… View more
Author(s): Joseph Gallagher , Kenneth McDonald , Mark Ledwidge , et al Added: 3 years ago
Patients with heart disease in Africa commonly present with heart failure both for admission to hospital1 and in the outpatient setting.2 Recent data suggests that, in line with high income countries, heart failure with preserved ejection fraction is also becoming more common.3 Data from the 12 clinical studies performed before 2005 in eight sub-Saharan Africa (SSA) countries have shown that up… View more
Author(s): Martin R Cowie , Michel Komajda Added: 3 years ago
Advances in diagnosis and treatment have improved the outlook for the estimated 26 million patients with heart failure (HF) worldwide,1 but there remains a continuing need for further reduction in mortality and hospitalisation and the associated social and financial consequences of the disease. In a European study of outcomes after HF hospitalisation, 17 % of patients died within 12 months and 44… View more
Author(s): Laura Kearney , Paul Wright , Sadeer Fhadil , et al Added: 3 years ago
Postpartum cardiomyopathy (PPCM) is a diagnosis of exclusion, where patients present with heart failure secondary to left ventricular (LV) systolic dysfunction towards the end of pregnancy or in the months following delivery, with no other cause of heart failure identified.1 PPCM is relatively uncommon, affecting between one in 5,000 and one in 10,000 births;2 it is thought to be more prevalent… View more
Foreword

Article

Author(s): Andrew JS Coats , Giuseppe Rosano Added: 3 years ago
We have great pleasure in introducing the second volume of Cardiac Failure Review to our readers. In recent weeks we have attended innovative conferences that have highlighted new devices that show great promise in heart failure treatment, one in Brussels, Belgium that coincided with the tragic events there, and one in Seoul, Korea – an impressive emerging Asian superstar. In heart failure news,… View more
MISSIONS Our primary mission is to develop translational approaches to Unmet Healthcare Needs for which solutions are unknown and/or underutilized. The TMA uses Evidence Building, Education, and Advocacy Programs to address these needs. TMA Mandates Support translational science through financing opportunities and medical activities Provide Continuing Medical Education (CME) and… View more
Author(s): Andrea Mortara , Lucia Vaira , Vittorio Palmieri , et al Added: 3 years ago
Innovative patient-centred interventions are required to improve the self-management of complex, costly and relapsing conditions, such as heart failure (HF). Mobile health (mHealth) technology is a promising tool that could potentially help us reach these goals, but evidence of its clinical benefits and the security of personal health information is still scarce. In view of the increasing number… View more
Author(s): Eilidh Hill , Jackie Taylor Added: 3 years ago
In developed countries, it is estimated that 1–2 % of the adult population has heart failure (HF), with the prevalence increasing to more than 10 % in those aged >70 years.1 Despite advances in therapies for heart failure with reduced ejection fraction (HFrEF), it remains a condition associated with significant morbidity and mortality, punctuated by episodes of unplanned hospitalisation.2 HF… View more
Author(s): Ovidiu Chioncel , Sean P Collins , Andrew P Ambrosy , et al Added: 3 years ago
Acute heart failure (AHF) is a heterogeneous clinical syndrome including diverse phenotypes sharing similar presenting signs and symptoms.1 The diversity of aetiologies and precipitants of HF and their specific pathophysiologic mechanisms, may result in distinct clinical profiles requiring specific treatment approaches. Pulmonary oedema (PO) is a common manifestation of AHF associated with a… View more